CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+18.02%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.06B
AUM Growth
+$1.06B
(-1.1%)
Cap. Flow
-$150M
Cap. Flow
% of AUM
-14.08%
Top 10 Holdings %
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
263
Reduced
171
Closed
24
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
$6.59M |
| 2 |
iShares Gold Trust Micro
IAUM
|
$4.62M |
| 3 |
Intuit
INTU
|
$3.73M |
| 4 |
SPDR Gold MiniShares Trust
GLDM
|
$3.6M |
| 5 |
T-Mobile US
TMUS
|
$2.35M |
Top Sells
| 1 |
Apple
AAPL
|
$17.4M |
| 2 |
NVIDIA
NVDA
|
$12.2M |
| 3 |
Microsoft
MSFT
|
$11.5M |
| 4 |
Amazon
AMZN
|
$8.86M |
| 5 |
Broadcom
AVGO
|
$8.43M |
Sector Composition
| 1 | Technology | 38.15% |
| 2 | Healthcare | 22.68% |
| 3 | Communication Services | 12.64% |
| 4 | Consumer Discretionary | 11.62% |
| 5 | Consumer Staples | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Zeta Global
ZETA
$4.41B
| $341K | 0.03% |
22,000
-93,000
| -81% | -$1.44M |
|
277
Sarepta Therapeutics
SRPT
$1.9B
| $338K | 0.03% |
19,739
+276
| +1% | +$4.72K |
|
278
Arcutis Biotherapeutics
ARQT
$1.86B
| $336K | 0.03% |
23,941
+144
| +0.6% | +$2.02K |
|
|
XNET
279
Xunlei
XNET
$457M
| $306K | 0.03% |
+75,500
| New | +$306K |
|
280
Vera Therapeutics
VERA
$1.44B
| $302K | 0.03% |
12,809
+22
| +0.2% | +$518 |
|
281
VF Corp
VFC
$5.8B
| $293K | 0.03% |
24,906
-39,000
| -61% | -$458K |
|
282
89bio
ETNB
$1.34B
| $288K | 0.03% |
29,320
+38
| +0.1% | +$373 |
|
283
ANI Pharmaceuticals
ANIP
$2.03B
| $284K | 0.03% |
4,349
-16
| -0.4% | -$1.04K |
|
284
Biohaven
BHVN
$1.68B
| $282K | 0.03% |
+20,000
| New | +$282K |
|
285
Edgewise Therapeutics
EWTX
$1.57B
| $277K | 0.03% |
21,120
+2,127
| +11% | +$27.9K |
|
286
Janux Therapeutics
JANX
$1.37B
| $275K | 0.03% |
11,885
+30
| +0.3% | +$693 |
|
287
Hilton Worldwide
HLT
$64.9B
| $272K | 0.03% |
1,021
| – | – |
|
288
Travere Therapeutics
TVTX
$1.56B
| $264K | 0.02% |
17,836
+36
| +0.2% | +$533 |
|
289
10x Genomics
TXG
$1.74B
| $258K | 0.02% |
22,313
+601
| +3% | +$6.96K |
|
290
Innoviva
INVA
$1.29B
| $253K | 0.02% |
12,608
+36
| +0.3% | +$723 |
|
|
CNTA
291
Centessa Pharmaceuticals
CNTA
$2.25B
| $252K | 0.02% |
19,181
+870
| +5% | +$11.4K |
|
292
Immunocore
IMCR
$1.62B
| $250K | 0.02% |
7,982
+35
| +0.4% | +$1.1K |
|
293
Structure Therapeutics
GPCR
$1.16B
| $248K | 0.02% |
11,967
+16
| +0.1% | +$332 |
|
294
CureVac
CVAC
$1.21B
| $246K | 0.02% |
45,222
+224
| +0.5% | +$1.22K |
|
295
Dynavax Technologies
DVAX
$1.19B
| $239K | 0.02% |
24,118
-768
| -3% | -$7.62K |
|
296
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $235K | 0.02% |
8,503
+77
| +0.9% | +$2.13K |
|
297
Aurinia Pharmaceuticals
AUPH
$1.58B
| $230K | 0.02% |
27,135
-413
| -1% | -$3.5K |
|
298
MannKind Corp
MNKD
$1.76B
| $228K | 0.02% |
61,044
+149
| +0.2% | +$557 |
|
299
Harrow
HROW
$1.44B
| $225K | 0.02% |
7,371
+227
| +3% | +$6.93K |
|
300
Autoliv
ALV
$9.53B
| $224K | 0.02% |
2,000
| – | – |
|